Cancer immunosurveillance and immunoediting: The roles of immunity in suppressing tumor development and shaping tumor immunogenicity

被引:607
作者
Smyth, MJ [1 ]
Dunn, GP
Schreiber, RD
机构
[1] Peter MacCallum Canc Ctr, Canc Immunol Program, E Melbourn, Vic 3002, Australia
[2] Washington Univ, Ctr Immunol, Dept Pathol & Immunol, St Louis, MO 63130 USA
来源
ADVANCES IN IMMUNOLOGY, VOL 90: CANCER IMMUNOTHERAPY | 2006年 / 90卷
关键词
D O I
10.1016/S0065-2776(06)90001-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cellular transformation and tumor development result from an accumulation Of mutational and epigenetic changes that alter normal cell growth and survival pathways. For the last 100 years, there has been a vigorous debate (is to whether the unmanipulated immune system can detect and eliminate such altered host derived cells despite the fact that cancer cells frequently express either abnormal proteins or abnormal levels of normal cellular proteins that function as tumor antigens. In this review, toe discuss the current state of this argument and point out some of the recent key experiments demonstrating that immunity not only protects the host from cancer development (i.e., provides a cancer immunosurveillance but also can promote tumor growth, sometimes by generating more aggressive tumors. The terminology "cancer immunoediting" has been used to describe this dual host protective and tumor promoting action Of immunity, and herein we summarize the ever-increasing experimental and clinical data that support the validity of this concept.
引用
收藏
页码:1 / 50
页数:50
相关论文
共 279 条
  • [1] AFFABRIS E, 1987, HAEMATOLOGICA, V72, P76
  • [2] Adjuvant-mediated tumor regression and tumor-specific cytotoxic response are impaired in MyD88-deficient mice
    Akazawa, T
    Masuda, H
    Saeki, Y
    Matsumoto, M
    Takeda, K
    Tsujimura, K
    Kuzushima, K
    Takahashi, T
    Azuma, I
    Akira, S
    Toyoshima, K
    Seya, T
    [J]. CANCER RESEARCH, 2004, 64 (02) : 757 - 764
  • [3] Paraneoplastic neurological degenerations: Keys to tumour immunity
    Albert, ML
    Darnell, RB
    [J]. NATURE REVIEWS CANCER, 2004, 4 (01) : 36 - 44
  • [4] Tumor-specific killer cells in paraneoplastic cerebellar degeneration
    Albert, ML
    Darnell, JC
    Bender, A
    Francisco, LM
    Bhardwaj, N
    Darnell, RB
    [J]. NATURE MEDICINE, 1998, 4 (11) : 1321 - 1324
  • [5] Albert ML, 2000, ANN NEUROL, V47, P9
  • [6] The HLA crossroad in tumor immunology
    Algarra, I
    Cabrera, T
    Garrido, F
    [J]. HUMAN IMMUNOLOGY, 2000, 61 (01) : 65 - 73
  • [7] Isolation of putative progenitor endothelial cells for angiogenesis
    Asahara, T
    Murohara, T
    Sullivan, A
    Silver, M
    vanderZee, R
    Li, T
    Witzenbichler, B
    Schatteman, G
    Isner, JM
    [J]. SCIENCE, 1997, 275 (5302) : 964 - 967
  • [8] The IFN gamma receptor: A paradigm for cytokine receptor signaling
    Bach, EA
    Aguet, M
    Schreiber, RD
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 : 563 - &
  • [9] NATURAL IMMUNITY - A T-CELL-INDEPENDENT PATHWAY OF MACROPHAGE ACTIVATION, DEFINED IN THE SCID MOUSE
    BANCROFT, GJ
    SCHREIBER, RD
    UNANUE, ER
    [J]. IMMUNOLOGICAL REVIEWS, 1991, 124 : 5 - 24
  • [10] Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
    Bauer, Stefan
    Groh, Veronika
    Wu, Jun
    Steinle, Alexander
    Phillips, Joseph H.
    Lanier, Lewis L.
    Spies, Thomas
    [J]. JOURNAL OF IMMUNOLOGY, 2018, 200 (07) : 2231 - 2233